Status: Recruiting
A Study of the Safety and Efficacy of the Intravenous and Intratumoral Injection of OVV-01 in Patients With Advanced Solid Tumours.
This is an open-label, single-arm, dose escalation clinical study to evaluate the safety and preliminary efficacy of OVV-01 Injection in patients with advanced solid tumors, following both intravenous (iv.) and intratumoral (it.) injections. This study consists of two parts: Part 1 is a dose escalation study of iv. administration; Part 2 is a dose escalation study of iv. and it. administration.
Participants needed: 18
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Joint Biosciences Ltd.Updated: Jun 15, 2026Locations: 1
Eligibility criteria
Be willing to sign the ICF, be able to understand the study, and be willing to f... [+7]
Patients with known brain metastases and/or clinically suspected brain metastase... [+19]